GRANT TYLER: Open Payments
NPI 1346641644 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 48 payments from 15 companies in 2025. Trend: 2023 $97 · 2024 $327 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $132 |
| Corium, LLC | 4 | $71 |
| Alkermes, Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Tris Pharma Inc | 3 | $46 |
| ABBVIE INC. | 1 | $31 |
| Lundbeck LLC | 1 | $23 |
Products named: Auvelity, REXULTI, TRINTELLIX, Azstarys, AUSTEDO XR, INGREZZA, ARISTADA, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
